Val G. Hemming

4.0k total citations · 2 hit papers
57 papers, 3.0k citations indexed

About

Val G. Hemming is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Val G. Hemming has authored 57 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Epidemiology, 24 papers in Public Health, Environmental and Occupational Health and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Val G. Hemming's work include Neonatal and Maternal Infections (23 papers), Respiratory viral infections research (22 papers) and Pneumonia and Respiratory Infections (14 papers). Val G. Hemming is often cited by papers focused on Neonatal and Maternal Infections (23 papers), Respiratory viral infections research (22 papers) and Pneumonia and Respiratory Infections (14 papers). Val G. Hemming collaborates with scholars based in United States, France and Australia. Val G. Hemming's co-authors include Gregory A. Prince, James C. Overall, Michael R. Britt, Jessie R. Groothuis, G. Fischer, Robert M. Chanock, Eric A. F. Simões, R L Horswood, Jorge C. G. Blanco and William J. Rodríguez and has published in prestigious journals such as New England Journal of Medicine, The Journal of Immunology and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Val G. Hemming

56 papers receiving 2.8k citations

Hit Papers

Prophylactic Administration of Respiratory Syncytial Viru... 1993 2026 2004 2015 1993 1997 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Val G. Hemming United States 25 2.1k 970 846 542 483 57 3.0k
Larry H. Taber United States 37 3.1k 1.5× 784 0.8× 1.1k 1.3× 272 0.5× 349 0.7× 71 4.0k
J Nikoskelainen Finland 34 1.2k 0.6× 381 0.4× 965 1.1× 589 1.1× 907 1.9× 109 3.6k
Elja Herva Finland 34 3.5k 1.7× 626 0.6× 599 0.7× 718 1.3× 395 0.8× 97 4.9k
Vincent A. Fulginiti United States 26 1.8k 0.9× 553 0.6× 836 1.0× 291 0.5× 642 1.3× 110 3.5k
Leonard E. Weisman United States 30 1.2k 0.6× 526 0.5× 425 0.5× 1.2k 2.2× 192 0.4× 76 2.4k
Cathrien A. Bruggeman Netherlands 35 2.3k 1.1× 334 0.3× 554 0.7× 339 0.6× 935 1.9× 144 4.0k
Helle Bossen Konradsen Denmark 34 2.7k 1.3× 263 0.3× 436 0.5× 650 1.2× 374 0.8× 72 3.7k
Fernando P. Polack United States 33 3.1k 1.5× 1.2k 1.2× 1.5k 1.7× 207 0.4× 821 1.7× 102 4.1k
Paul Andersen Denmark 25 1.1k 0.5× 279 0.3× 738 0.9× 175 0.3× 306 0.6× 88 2.5k
Janak A. Patel United States 28 1.5k 0.7× 849 0.9× 432 0.5× 246 0.5× 428 0.9× 87 2.9k

Countries citing papers authored by Val G. Hemming

Since Specialization
Citations

This map shows the geographic impact of Val G. Hemming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Val G. Hemming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Val G. Hemming more than expected).

Fields of papers citing papers by Val G. Hemming

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Val G. Hemming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Val G. Hemming. The network helps show where Val G. Hemming may publish in the future.

Co-authorship network of co-authors of Val G. Hemming

This figure shows the co-authorship network connecting the top 25 collaborators of Val G. Hemming. A scholar is included among the top collaborators of Val G. Hemming based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Val G. Hemming. Val G. Hemming is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Hübner, Marc P., Kristin E. Killoran, Michael Rajnik, et al.. (2012). Chronic Helminth Infection Does Not Exacerbate Mycobacterium tuberculosis Infection. PLoS neglected tropical diseases. 6(12). e1970–e1970. 35 indexed citations
3.
Groothuis, Jessie R., et al.. (2011). Prevention of serious respiratory syncytial virus-related illness. II: Immunoprophylaxis. Advances in Therapy. 28(2). 110–125. 28 indexed citations
4.
Jensen, Kirk, Aneeta Patel, О. С. Ларін, et al.. (2010). Human herpes simplex viruses in benign and malignant thyroid tumours. The Journal of Pathology. 221(2). 193–200. 26 indexed citations
5.
Awomoyi, Agnes A., Prasad Rallabhandi, Toni I. Pollin, et al.. (2007). Association of TLR4 Polymorphisms with Symptomatic Respiratory Syncytial Virus Infection in High-Risk Infants and Young Children. The Journal of Immunology. 179(5). 3171–3177. 146 indexed citations
6.
Rallabhandi, Prasad, Jessica K. Bell, Marina S. Boukhvalova, et al.. (2006). Analysis of TLR4 Polymorphic Variants: New Insights into TLR4/MD-2/CD14 Stoichiometry, Structure, and Signaling. The Journal of Immunology. 177(1). 322–332. 194 indexed citations
7.
Ottolini, Martin G., David Porter, Val G. Hemming, & Gregory A. Prince. (2000). Enhanced Pulmonary Pathology in Cotton Rats upon Challenge After Immunization with Inactivated Parainfluenza Virus 3 Vaccines. Viral Immunology. 13(2). 231–236. 25 indexed citations
8.
Colasurdo, Giuseppe N., Val G. Hemming, Gregory A. Prince, et al.. (1998). Human Respiratory Syncytial Virus Produces Prolonged Alterations of Neural Control in Airways of Developing Ferrets. American Journal of Respiratory and Critical Care Medicine. 157(5). 1506–1511. 44 indexed citations
9.
Johnson, Syd, Cynthia N. Oliver, Gregory A. Prince, et al.. (1997). Development of a Humanized Monoclonal Antibody (MEDI‐493) with Potent In Vitro and In Vivo Activity against Respiratory Syncytial Virus. The Journal of Infectious Diseases. 176(5). 1215–1224. 513 indexed citations breakdown →
10.
Piazza, Franco M., Susan A. Johnson, Miriam E. R. Darnell, et al.. (1997). Immunoprophylaxis of Group B Respiratory Syncytial Virus Infection in Cotton Rats. The Journal of Infectious Diseases. 175(4). 932–934. 4 indexed citations
11.
Ottolini, Martin G. & Val G. Hemming. (1997). Prevention and Treatment Recommendations for Respiratory Syncytial Virus Infection. Drugs. 54(6). 867–884. 32 indexed citations
12.
Rodríguez, William J., William C. Gruber, Jessie R. Groothuis, et al.. (1996). RESPIRATORY SYNCYTIAL VIRUS IMMUNE HUMAN GLOBULIN, (RSVIg) AS TREATMENT OF RSV LOWER RESPIRATORY TRACT INFECTIONS (LRI) IN CHILDREN. †1085. Pediatric Research. 39. 183–183. 4 indexed citations
13.
Weisman, Leonard E., Bascom F. Anthony, Val G. Hemming, & G. Fischer. (1993). Comparison of group B streptococcal hyperimmune globulin and standard intravenously administered immune globulin in neonates. The Journal of Pediatrics. 122(6). 929–937. 19 indexed citations
14.
Weisman, Leonard E., Barbara J. Stoll, Thomas Rubio, et al.. (1992). Intravenous immune globulin therapy for early-onset sepsis in premature neonates. The Journal of Pediatrics. 121(3). 434–443. 56 indexed citations
15.
Stoll, Barbara J., et al.. (1992). Early-onset group B streptococcal sepsis: A current assessment. The Journal of Pediatrics. 121(3). 428–433. 108 indexed citations
16.
Fischer, G., Leonard E. Weisman, & Val G. Hemming. (1992). Directed immune globulin for the prevention or treatment of neonatal group B streptococcal infections: A review. Clinical Immunology and Immunopathology. 62(1). S92–S97. 13 indexed citations
17.
Fischer, G., et al.. (1990). Polyvalent Group B Streptococcal Immune Globulin for Intravenous Administration: Overview. Clinical Infectious Diseases. 12(Supplement_4). S483–S491. 23 indexed citations
18.
Weisman, Leonard E., G. Fischer, Val G. Hemming, et al.. (1989). Phannacokinetics of Intravenous Immunoglobulin in Neonates. Vox Sanguinis. 57(4). 243–248. 24 indexed citations
19.
Hemming, Val G., et al.. (1987). Proliferation of group B streptococci in human amniotic fluid in vitro. American Journal of Obstetrics and Gynecology. 156(1). 95–99. 13 indexed citations
20.
Fischer, G., et al.. (1982). Pneumococcal Sepsis with False-Negative Blood Cultures. American Journal of Clinical Pathology. 78(3). 348–350. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026